1. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer
    Baohong Jiang et al, 2022, Disease Markers CrossRef
  2. NUF2 overexpression contributes to epithelial ovarian cancer progression via ERBB3-mediated PI3K-AKT and MAPK signaling axes
    Ruobing Leng et al, 2022, Frontiers in Oncology CrossRef
  3. Identification and Validation of Autophagy-Related Genes in Primary Ovarian Insufficiency by Gene Expression Profile and Bioinformatic Analysis
    Siji Lv et al, 2022, Analytical Cellular Pathology CrossRef
  4. HIPEC for gynaecological malignancies: A last update (Review)
    Chrysoula Margioula‑Siarkou et al, 2023, Medicine International CrossRef
  5. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer
    Xianwen Hu et al, 2022, Frontiers in Oncology CrossRef
  6. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
    Daniele Marrelli et al, 2022, Cancers CrossRef
  7. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
    Qiaonan Guo et al, 2022, Disease Markers CrossRef
  8. ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration
    Can Wang et al, 2022, Disease Markers CrossRef
  9. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation
    Sihan Chen et al, 2022, Frontiers in Oncology CrossRef
  10. MicroRNAs as Potential Biomarkers in Gynecological Cancers
    Joanna Miśkiewicz et al, 2023, Biomedicines CrossRef
  11. Systematic Pan-Cancer Analysis and Experimental Verification Identify FOXA1 as an Immunological and Prognostic Biomarker in Epithelial Ovarian Cancer
    Kai Wang et al, 2022, Disease Markers CrossRef
  12. Polygenic Risk Score Predicts Modified Risk in BRCA1 Pathogenic Variant c.4035del and c.5266dup Carriers in Breast Cancer Patients
    Egija Berga-Švītiņa et al, 2023, Cancers CrossRef